Detalhe da pesquisa
1.
Nanofiltration as a robust method contributing to viral safety of plasma-derived therapeutics: 20 years' experience of the plasma protein manufacturers.
Transfusion
; 60(11): 2661-2674, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32815181
2.
Prion removal capacity of plasma protein manufacturing processes: a data collection from PPTA member companies.
Transfusion
; 53(9): 1894-905, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23252676
3.
Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies.
Transfusion
; 51(7): 1412-30, 2011 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-21251002
4.
Robustness of solvent/detergent treatment of plasma derivatives: a data collection from Plasma Protein Therapeutics Association member companies.
Transfusion
; 49(9): 1931-43, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19497061
5.
Effective virus inactivation and removal by steps of Biotest Pharmaceuticals IGIV production process.
Results Immunol
; 2: 19-24, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-24371563